Sports Injury Centre and SAI Sign Landmark MoU for Athlete Care
In a major boost to the nation’s sports ecosystem, the Sports Injury Centre (SIC) at Safdarjung Hospital and the Sports Authority of India (SAI) have signed...
Glenmark Pharmaceuticals Inc., USA Launches Olanzapine for Injection
Glenmark Pharmaceuticals Inc., USA (Glenmark) has announced the official launch of Olanzapine for Injection, 10mg/vial, available as a Single-Dose Vial.
The newly launched product is bioequivalent...
GSK-partnered Hansoh Pharma reports positive Phase III lung cancer data.
GSK plc shared an announcement from its licensor, HansohPharmaceutical Group Co., Ltd., confirming that the pivotal phase III ARTEMIS-008 trial evaluating risvutatug rezetecan(Ris-Rez) met its primary endpoint...
Army Hospital R&R Performs First Robotic Stereotactic Brain Stem Biopsy
In a landmark achievement for military medicine, the Neurosurgery Department at the Army Hospital Research & Referral (R&R) has successfully performed the first-ever robotic...
Johnson & Johnson Secures FDA Approval for Dual-Energy Cardiac Ablation Catheter
Johnson & Johnson has secured U.S. regulatory clearance for its newest electrophysiology device, the Dual Energy THERMOCOOL SMARTTOUCH SF Platform. The system lets doctors...
Vertex to Acquire Crinetics Pharmaceuticals for $10.0 Billion, Expanding Rare Endocrine Disease Portfolio
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. announced a definitive agreement under which Vertex will acquire Crinetics for $85.00 per share in...